Sheel Biotech Limited
Minimum investment
Bidding date
30 Sep - 03 Oct 2025
Price range
₹59 - ₹63
Minimum quantity
4,000
Minimum investment
₹1,18,000
Issue size
₹34.02 Cr.
IPO doc (link)
RHP docsListing exchange
NSE/BSE
Category | Subscription |
|---|---|
Qualified Institutional Buyers | - |
Retail Individual Investor | - |
Non-Institutional Investor | - |
Others | - |
Total | - |
Incorporated in 1991, Sheel Biotech Ltd. is engaged in biotechnology, floriculture, greenhouses, and organic projects. The company provides high-quality planting material for fruits, vegetables, and ornamental crops using tissue culture and hydroponics techniques.
Sheel Biotech also offers greenhouse construction, farmer services, and training through Farmer Producer Organizations (FPOs). The company has a strong presence in organic adoption and certification services, landscaping solutions, and skill development programs for farmers and agripreneurs.
The company holds ISO 9001:2015, 14001:2015, and 45001:2018 certifications and its R&D laboratory is recognized by the Department of Biotechnology (DBT) and Department of Science & Technology (DST), Government of India.
Expertise in Biotechnology and Organic Farming: Sheel Biotech has established strong capabilities in biotechnology, floriculture, and organic farming, which forms the foundation of its business.
Recognized R&D and Certifications: The company operates with ISO certifications and government-recognized R&D facilities, ensuring quality, safety, and innovation in its operations.
Diversified Business Model: With offerings ranging from planting materials to greenhouse construction and organic certification services, Sheel Biotech benefits from a diversified revenue stream.
Established Client Relationships: The company has long-standing associations with both government and private sector clients, providing consistent project opportunities and business stability.
Seasonal Dependency in Agriculture: A significant part of the company’s business is dependent on seasonal agricultural demand, which can affect revenue stability.
Equity Dilution Impact: Promoter holding will drop from 96.99% pre-issue to 71.26% post-issue, reflecting a high level of equity dilution.
Revenue Volatility: While the company reported Rs. 92.55 Cr in income during FY24, revenues dropped to Rs. 3.99 Cr in the quarter ended May 2024, showing fluctuations in financial performance.
Competitive Industry Landscape: The agri-biotech and floriculture sectors are highly competitive, with several established players, which could impact growth and market share.
Active IPOs | |
|---|---|
Company name | Bid starts |
Cmr Green Technologies | 03-06-2026 |
Hexagon Nutrition | 05-06-2026 |